Sophocarpine : The Multi-Target Quinolizidine Alkaloid, Master of Inflammation, Pain & Cardiovascular Protection

Sophocarpine: The tetracyclic quinolizidine alkaloid derived from ancient medicinal legumes, a sophisticated molecular architect capable of restoring balance across multiple organ systems. This bioactive compound, concentrated in the roots and seeds of various Sophora species, functions as a potent modulator of inflammatory cascades, a protector of cardiomyocytes, and a regulator of pain signaling pathways. Its unique alpha,beta-unsaturated lactam structure provides a flexible reactive site for engaging with diverse molecular targets, positioning sophocarpine as a promising therapeutic candidate for conditions ranging from rheumatoid arthritis and viral infections to pulmonary hypertension and cardiac arrhythmias.

1. Overview:

Sophocarpine is a natural tetracyclic quinolizidine alkaloid belonging to the matrine-type family, with the molecular formula C15H22N2O and a molecular weight of 246.35 grams per mole. Its primary actions are remarkably diverse, stemming from its ability to modulate multiple key signaling pathways including NF-kB, MAPK, PI3K/AKT, and AMPK. It functions as a potent anti-inflammatory agent by suppressing pro-inflammatory cytokines like TNF-alpha and IL-6, as an analgesic by inhibiting TRP channels, as an antiviral and antiparasitic compound, as an anticancer agent with selective cytotoxicity, and as an organoprotective molecule for the heart, liver, and lungs. Its unique structure features an alpha,beta-unsaturated carbonyl group that serves as a flexible reactive site, allowing it to interact with nucleophiles in biological systems and making it an ideal starting material for drug synthesis and structural modification.

2. Origin & Common Forms:

Sophocarpine is not found in isolation but as a key bioactive constituent of several important medicinal plants, particularly those in the genus Sophora. These plants have been used for centuries in traditional healthcare systems across East Asia.

· Primary Botanical Sources: The compound is predominantly derived from Sophora alopecuroides L. (commonly known as foxtail-like sophora), Sophora flavescens Ait. (Kushen, or bitter root), Sophora subprostrata, Sophora viciifolia, Sophora tonkinensis Gagnep., and to a lesser extent, Daphniphyllum oldhamii (Hemsl.) K. Rosenthal.

· Tissue Distribution: Within these plants, sophocarpine is concentrated in the roots, seeds, and sometimes the aerial parts, where it serves as a natural defense compound against herbivores and pathogens.

· Related Alkaloids: It is part of a larger family of bioactive quinolizidine alkaloids found in Sophora species, including matrine, oxymatrine, sophoridine, aloperine, and cytisine, each with distinct but overlapping pharmacological profiles.

3. Common Supplemental Forms:

Sophocarpine is not typically available as an isolated dietary supplement in Western markets. Its use is primarily in research settings, as a pharmaceutical lead compound, and as a component of traditional herbal formulations.

· Standardized Herbal Extracts: Extracts of Sophora flavescens root (Kushen) or Sophora alopecuroides are sometimes available as dietary supplements, standardized to contain a percentage of total alkaloids, including sophocarpine, matrine, and oxymatrine.

· Research Grade Isolate: High-purity sophocarpine (>98%) is available from chemical suppliers for laboratory research and preclinical studies. This form is explicitly labeled "for research use only" and is not intended for human consumption.

· Traditional Preparations: In Traditional Chinese Medicine, Sophora roots are prepared as decoctions, powders, or tinctures, often in combination with other herbs, for conditions involving "damp-heat," inflammation, and skin disorders.

· Pharmaceutical Development: Sophocarpine is being investigated as a lead compound for developing new drugs targeting inflammation, viral infections, cancer, and cardiovascular diseases.

4. Natural Origin:

The compound is biosynthesized exclusively by plants, primarily as a secondary metabolite for chemical defense.

· Plant Sources: The definitive sources are the roots and seeds of various Sophora species (family Fabaceae), particularly Sophora alopecuroides and Sophora flavescens. These plants are native to Central Asia, Siberia, and East Asia, including China, Mongolia, and Korea.

· Biosynthetic Pathway: Sophocarpine is derived from the amino acid lysine through a dedicated quinolizidine alkaloid biosynthetic pathway. This pathway involves enzyme-catalyzed cyclization and oxidation steps that construct the characteristic tetracyclic ring system. The presence of the alpha,beta-unsaturated lactam moiety is a defining feature that distinguishes it from its saturated analog, matrine.

5. Synthetic / Man-made:

Sophocarpine can be synthesized chemically, but commercial production for research purposes typically relies on extraction from plant sources due to the complexity and cost of total synthesis.

· Extraction and Isolation: Dried, powdered plant material (usually Sophora roots) is extracted with organic solvents such as ethanol or methanol. The crude extract is then acidified to convert the alkaloids to their water-soluble salt forms, allowing separation from non-alkaloidal compounds. After basification, the free alkaloids are re-extracted with organic solvents. Sophocarpine is then isolated from the mixture of related alkaloids (matrine, oxymatrine, sophoridine) using chromatographic techniques such as column chromatography or preparative HPLC. Final purification often involves crystallization.

· Synthetic Approaches: Total synthesis of sophocarpine has been achieved in research laboratories, but it is a multi-step process that is not economically viable for large-scale production. The compound's structure, with its four fused rings and specific stereochemistry, presents significant synthetic challenges.

6. Commercial Production:

· Precursors: Cultivated Sophora flavescens or Sophora alopecuroides plants, harvested for their roots.

· Process: Large-scale extraction follows the principles of alkaloid isolation described above, scaled up using industrial extraction equipment. The process involves percolation or reflux extraction, followed by liquid-liquid extraction, and large-scale chromatography. The final product is crystallized and dried to a white to off-white powder.

· Purity and Efficacy: Research-grade sophocarpine is offered at purities exceeding 98%, verified by HPLC. Its efficacy in pharmacological studies is directly linked to its purity and the correct stereoisomeric form, which is the naturally occurring (-)-sophocarpine.

7. Key Considerations:

The Multi-Target, Multi-Pathway Therapeutic Potential. Sophocarpine's significance lies in its remarkable pleiotropy. It is not a single-target drug but a multi-functional molecule that engages with several fundamental signaling pathways underlying chronic disease. Its ability to simultaneously inhibit NF-kB-mediated inflammation, modulate MAPK and PI3K/AKT signaling, and regulate ion channel activity positions it as a promising candidate for complex conditions where single-target therapies often fall short. The recent surge in research, including high-quality studies published in 2024, 2025, and 2026 on its effects in pulmonary hypertension, atopic dermatitis, and cardiac arrhythmias, underscores its potential to translate from traditional medicine to modern pharmacotherapy. Its unique structure also makes it a valuable scaffold for medicinal chemistry efforts aimed at improving potency, selectivity, and pharmacokinetic properties.

8. Structural Similarity:

Sophocarpine belongs to the matrine-type subclass of quinolizidine alkaloids. Its molecular structure is defined by a tetracyclic framework consisting of four fused rings forming a rigid, cage-like scaffold. The key features include two nitrogen atoms incorporated into the ring system and an alpha,beta-unsaturated lactam ring (a six-membered ring containing a nitrogen and a carbonyl group with a conjugated double bond). This alpha,beta-unsaturated carbonyl moiety is a critical structural element that distinguishes sophocarpine from its close analog matrine, which has a saturated lactam ring. This unsaturation provides a site for Michael addition reactions with biological nucleophiles, which may contribute to its distinct pharmacological activities. Its stereochemistry is precisely defined, with four chiral centers in the (1R,2R,9S,17S) configuration.

9. Biofriendliness:

· Utilization: Sophocarpine is absorbed after oral administration. Pharmacokinetic studies show that its distribution in the body conforms to a two-compartment model. It can be detected in various tissues, indicating good tissue penetration.

· Metabolism and Excretion: It has a relatively short half-life, suggesting rapid metabolism and clearance. It is primarily metabolized in the liver, and its metabolites are excreted in urine. The specific enzymes involved in its metabolism are still under investigation, but cytochrome P450 enzymes are likely candidates.

· Toxicity: Sophocarpine exhibits a dose-dependent toxicity profile. The oral LD50 in rats is reported as 196 milligrams per kilogram, and the intraperitoneal LD50 is 124 milligrams per kilogram. This indicates that the compound has a moderate toxicity profile and a therapeutic window that requires careful dose optimization. High doses can cause adverse effects, particularly on the cardiovascular and nervous systems. A review from 2024 notes that although pharmacological effects are well-documented, systematic toxicity and safety assessments are still limited and require further research.

10. Known Benefits (Scientifically Supported):

· Anti-inflammatory Effects: Suppresses pro-inflammatory cytokines including TNF-alpha, IL-6, and IL-1beta in various models. It has shown efficacy in animal models of rheumatoid arthritis, osteoarthritis, ulcerative colitis, and implant loosening by downregulating NF-kB, MAPK, and PI3K/AKT signaling pathways.

· Cardiovascular Protection:

· Pulmonary Hypertension: A 2026 study demonstrated that sophocarpine significantly alleviates inflammatory response and apoptosis in pulmonary hypertension models, reduces pulmonary artery pressure, and restores the balance of pulmonary artery remodeling.

· Antiarrhythmic Effects: Research from 2025 showed that sophocarpine has multiple ion channel blocking effects, inhibiting L-type calcium currents, transient outward potassium currents, and hERG potassium channels. It prolonged action potential duration and demonstrated antiarrhythmic activity in both in vitro and in vivo models of ventricular tachyarrhythmias.

· Analgesic and Antipruritic Effects: A 2026 study published in Acta Pharmacologica Sinica showed that sophocarpine alleviates chronic itch in a mouse model of atopic dermatitis by inhibiting spinal astrocyte reactivity and pro-inflammatory signaling. It also inhibits TRPA1 and TRPV1 channels, which are key mediators of pain and itch.

· Anticancer Activity: Exhibits inhibitory effects against various cancer cell lines, including Walker 256 carcinosarcoma. The mechanisms involve induction of apoptosis, cell cycle arrest, and modulation of signaling pathways that control proliferation and survival.

· Antiviral and Antiparasitic Effects: Demonstrates activity against certain viruses and parasites. It has been investigated as a natural control agent for red imported fire ants and shows aphicidal effects on pea aphids, indicating its broad-spectrum biocidal properties.

11. Purported Mechanisms:

· NF-kB Pathway Inhibition: Suppresses the activation of nuclear factor kappa-B, a master transcription factor controlling the expression of numerous pro-inflammatory genes. This is a central mechanism underlying its anti-inflammatory effects in conditions like arthritis, colitis, and pulmonary hypertension.

· MAPK and PI3K/AKT Modulation: Influences these key signaling cascades involved in cell proliferation, survival, and inflammation. Modulation of these pathways contributes to its effects on osteoarthritis, cancer, and organ protection.

· Ion Channel Regulation: Inhibits multiple ion channels including L-type calcium channels, transient outward potassium channels, and hERG potassium channels. This multi-channel blocking effect underlies its antiarrhythmic properties by stabilizing cardiac electrical activity.

· TRP Channel Inhibition: Blocks TRPA1 and TRPV1 channels, which are expressed on sensory neurons and mediate pain and itch signaling. This contributes to its analgesic and antipruritic effects.

· Astrocyte Reactivity Suppression: In the spinal cord, it inhibits the activation of astrocytes and reduces their production of pro-inflammatory mediators, alleviating chronic itch in atopic dermatitis models.

· AMPK Activation: May activate AMP-activated protein kinase, a cellular energy sensor involved in metabolic regulation and organ protection.

12. Other Possible Benefits Under Research:

· Endocrine Regulation: Preliminary evidence suggests potential effects on glucose metabolism and insulin sensitivity, with possible applications in type 1 diabetes.

· Multi-Organ Protection: Studies indicate hepatoprotective effects against liver injury, as well as protective effects on other organs through its anti-inflammatory and anti-apoptotic actions.

· Antifibrotic Effects: In pulmonary hypertension models, it helped restore the balance of pulmonary artery remodeling, suggesting potential anti-fibrotic properties.

· Agricultural Applications: Its insecticidal properties make it a candidate for development as a natural pesticide.

13. Side Effects:

· Dose-Dependent Toxicity: At high doses, sophocarpine can be toxic. The reported LD50 values indicate a moderate toxicity profile. Symptoms of overdose may include effects on the central nervous system and cardiovascular system.

· Cardiovascular Effects: Due to its ion channel blocking activity, high doses could potentially cause bradycardia, heart block, or other cardiac conduction abnormalities. This is both a therapeutic mechanism and a potential safety concern at supra-therapeutic levels.

· Gastrointestinal Distress: As with many alkaloids, high doses may cause nausea, vomiting, or abdominal discomfort.

· Limited Human Data: Most toxicity data comes from animal studies. Comprehensive human safety assessments are still limited, as noted in the 2024 review.

14. Dosing & How to Take:

· Research Context: Sophocarpine is not approved for human use as a isolated supplement. All dosing information is derived from preclinical studies.

· Animal Study Doses: In the 2026 pulmonary hypertension study, sophocarpine was administered at varying concentrations to achieve therapeutic effects. In the 2026 atopic dermatitis study, doses of 1, 5, 10, and 20 milligrams per kilogram per day were tested via intraperitoneal injection, with dose-dependent effects observed.

· Antiarrhythmic Study Doses: In the 2025 cardiac study, sophocarpine was tested at 12.5, 25.0, and 50.0 milligrams per kilogram in guinea pigs, with the highest dose demonstrating significant antiarrhythmic activity.

· Traditional Use: In Traditional Chinese Medicine, Sophora root decoctions are prepared according to classical formulas. The dose of sophocarpine in these preparations is not standardized and varies widely.

· How to Take: There is no established safe or effective dose for human use. Any use should be under the guidance of a qualified healthcare professional familiar with the research and risks.

15. Tips to Optimize Benefits (Research Context):

· Synergistic Combinations in Herbal Formulas: In traditional medicine, Sophora roots are often combined with other herbs. Modern research suggests that combinations with other alkaloids like matrine or oxymatrine may produce synergistic effects.

· Structural Modification: Medicinal chemistry efforts focused on modifying the alpha,beta-unsaturated lactam group or other regions of the molecule may yield analogs with improved potency, selectivity, and pharmacokinetic profiles.

· Targeted Disease Selection: Based on current evidence, the most promising therapeutic areas for further development include inflammatory and autoimmune diseases, cardiovascular conditions (especially pulmonary hypertension and arrhythmias), and chronic itch/pain syndromes.

16. Not to Exceed / Warning / Interactions:

· Drug Interactions:

· Cardiovascular Medications: Due to its effects on ion channels and heart rate, sophocarpine may interact with antiarrhythmic drugs, beta-blockers, calcium channel blockers, and other medications that affect cardiac conduction.

· CNS Depressants: May have additive effects with sedatives or other central nervous system depressants.

· CYP450 Substrates: The specific metabolic pathways are not fully elucidated, but potential interactions with drugs metabolized by cytochrome P450 enzymes should be considered.

· Medical Conditions:

· Cardiac Conditions: Individuals with pre-existing heart conditions, bradycardia, heart block, or electrolyte disturbances should avoid sophocarpine due to its effects on cardiac ion channels.

· Pregnancy and Lactation: Absolutely contraindicated. Sophocarpine has not been studied for safety in pregnancy and may pose risks to the developing fetus or nursing infant.

· Liver or Kidney Disease: May affect the metabolism and excretion of the compound, potentially leading to accumulation and toxicity.

· Toxicity Warning: The LD50 values indicate that sophocarpine has a moderate toxicity profile. It should not be used in high doses or for prolonged periods without medical supervision.

17. LD50 and Safety:

· Acute Toxicity (LD50): According to toxicological data, the oral LD50 in rats is 196 milligrams per kilogram, and the intraperitoneal LD50 is 124 milligrams per kilogram.

· Human Safety: No established safe dose for humans. The compound is not approved for human use as an isolated substance. A 2024 comprehensive review emphasized that while pharmacological effects are well-documented, toxicity and safety assessments and reports on molecular mechanisms of its pharmacological actions have been limited. Further research and evaluation are needed to promote its clinical application.

18. Consumer Guidance:

· Label Literacy: For herbal products containing Sophora, look for the botanical name (e.g., Sophora flavescens root extract) and any standardization information (e.g., "standardized to contain X% total alkaloids"). Be aware that sophocarpine content is rarely specified.

· Quality Assurance: Choose products from reputable manufacturers that follow Good Manufacturing Practices and provide third-party testing for purity and contaminants. Traditional herbal products should be sourced from established brands with a history of safe use.

· Regulatory Status: Sophocarpine is not approved as a dietary supplement ingredient in most Western countries. It is a research chemical and a component of traditional herbal medicines.

· Manage Expectations: Sophocarpine is a potent, multi-target alkaloid with genuine therapeutic potential, but it is not a supplement for casual self-experimentation. Its use should be informed by scientific understanding and professional guidance. The current body of research, including studies from 2024 through 2026, is painting a picture of a compound with significant promise for treating serious conditions like pulmonary hypertension, cardiac arrhythmias, and chronic inflammatory diseases. However, translating this promise from the laboratory to the clinic requires rigorous safety and efficacy studies in humans. For now, sophocarpine remains a fascinating subject of pharmacological research and a testament to the therapeutic potential hidden within traditional medicinal plants.